Capecitabine vs 5‐FU‐containing regimens
Treatment discontinuation due to toxicity · people with advanced gastric cancer
Capecitabine showed no clear difference in treatment discontinuation due to toxicity compared with 5‐FU‐containing regimens (low certainty).
1 finding from 1 review
- OR 0.99 [0.56, 1.77]1 study · 311 participantsLow